French Study Says Pfizer-Biontech Vaccine Less Effective against Indian Variant
- Tweet
Send to Kindle
A study by France’s Pasteur Institute found people who had received two doses of Pfizer saw a three-fold reduction in their antibodies against the B. 1.617 variant.
The Pfizer vaccine is slightly less effective but appears to still protect against the more transmissible Covid-19 variant first identified in India, according to a study by France’s Pasteur Institute.
“Despite slightly diminished efficacy, the Pfizer vaccine probably protects” against the Indian variant, according to laboratory test results, said Olivier Schwartz, the institute’s director and co-author of the study that was published on the BioRxiv website ahead of peer review.
The study sampled 28 health care workers in the city of Orleans. Sixteen of them had received two doses of the Pfizer vaccine, while 12 had received one dose of the AstraZeneca vaccine.
People who had received two doses of Pfizer saw a three-fold reduction in their antibodies against the Indian variant, B. 1.617, according to the study, but were still protected.
“The situation was different with the AstraZeneca vaccine, which induced particularly low levels of antibodies neutralising” the Indian variant, the study said.
Patients who had Covid-19 within the past year and people vaccinated with two doses of Pfizer retained enough antibodies to be protected against the Indian variant, but three to six times less antibodies than against the UK variant, said scientists.
Since first emerging in late 2019 in China, the SARS-CoV-2 virus that causes Covid-19 has developed several variants, usually named for the places where it first appeared including the so-called South Africa and UK strains.
The variant first detected in India appears to be much more transmissible than earlier variations. It has now been officially recorded in 53 territories, according to a World Health Organization report./scmp
Bulgaria’s Doctors Demand 25% Pay Rise as Health System “On the Brink”
The Bulgarian Medical Association has called for an urgent overhaul of healthcare funding, insisting on a 25 percent increase in the prices of clinical pathways and all medical services, alongside a revision of the user fee for hospital stays
Measles Cases in Bulgaria Rise Above 70, Most Infections Concentrated in Vratsa Region
Health authorities report that measles infections in Bulgaria have surpassed 70 confirmed cases, with a total of 73 registered as of April 3
Measles Cases Rise to 66 in Bulgaria as Sofia Records First Infection
Health authorities have reported a total of 66 confirmed measles cases in Bulgaria, with the first infection now recorded in Sofia, according to data published on the Ministry of Health’s epidemic monitoring platform.
Bulgaria Equips All Emergency Centers with Fentanyl Antidote amid Rising Overdose Risks
All emergency medical centers across Bulgaria have now been equipped with the opioid antidote Naloxone, a development confirmed by the Ministry of Health. The drug is used in cases of overdose and is considered critical for saving lives in emergencies inv
Measles Cases in Bulgaria Rise to 43, Majority Among Children
A total of 43 measles infections have been recorded across three regions in Bulgaria, according to data released by the Ministry of Health on March 30
Over 17,000 Abortions Reported in Bulgaria Last Year, 1,600 Involving Teenagers
Last year, Bulgaria recorded over 17,000 abortions, according to data compiled by the National Center for Public Health and Analysis
